Safety and Tolerability of MORAb-022 in Healthy and Rheumatoid Arthritis Subjects

Summary

This is a randomized, double-blind, placebo-controlled, single-dose, dose escalation study in healthy male and or female subjects and subjects with Rheumatoid Arthritis (RA) to determine the safety and tolerability of MORAb-022.

Timeline

Start

2013-05

Primary completion

2014-07

Completion

2014-07

Drugs

Indications